Inc. (NASDAQ:ETNB), with a market capitalization of $1.14 billion, is a clinical-stage biopharmaceutical company focusing on the development of innovative therapies for the treatment of liver and ...

Celldex Therapeutics , Inc. (NASDAQ:CLDX), with a market capitalization of $1.72 billion, is a biopharmaceutical company focused on developing innovative therapies for challenging diseases, with its ...

Naporafenib is Erasca’s main candidate, and it has Fast Track status for NRASm melanoma. See why I rate ERAS stock as a buy.

Lockheed Martin had a rough Q4, missing sales and EPS estimates, with unplanned charges impacting earnings. Despite the poor ...

NEW YORK, NY / ACCESS Newswire / January 26, 2025 / Rosen Law Firm PAWHY: Rosen Law Firm, a global investor rights law firm, announces an ...

EARNINGS FORECAST: Roche's core earnings per share are expected to come in at 18.59 francs, according to the Visible Alpha consensus. For 2023, the company reported core EPS of 18.57 francs. As of ...

John Marshall Bancorp, Inc. (Nasdaq: JMSB) (the "Company"), parent company of John Marshall Bank (the "Bank"), reported net income of $4.8 million ($0.33 per diluted common share) for the quarter ...

Weave Pattern: Most cotton sheets are made in a percale or sateen weave. Percale is a favorite for hot sleepers due to its ...

V.F. Corporation (NYSE:VFC) shares are trading higher in the premarket on Wednesday after the third-quarter FY25 earnings.

Rogers tops $20 billion in annual revenue in 2024 as more Canadians choose Rogers Wireless and Internet than any other carrier in Canada Led all Canadian carriers with combined mobile phone and ...

Stocks including Appen, Articore and Mineral Resources all dipped following December quarter reports on Thursday.

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...